Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Public Buy-In Of Personalized Medicine Requires Dialogue – Tufts’ Kaitin

Executive Summary

Improving the general public's understanding of drug development and delivery will be necessary to fully leverage the potential of personalized medicine, Tufts Center for the Study of Drug Development Director Kenneth Kaitin said

You may also be interested in...

PhRMA Patient Assistance Plan Is Template For Future Initiatives – BMS’ Dolan

PhRMA's Partnership for Prescription Assistance could serve as a template for future outreach efforts by the pharmaceutical industry, incoming Chairman Peter Dolan (Bristol-Myers Squibb) suggested

PhRMA’s Evidence-Based Medicine Principles Emphasize Individual Decisions

The Pharmaceutical Research & Manufacturers of America's principles for the use of evidence-based medicine emphasize that such data be used to "empower" patients and physicians

PhRMA DTC Principles Compliance To Get Independent Panel Review In 2007

PhRMA is giving itself one year to monitor member companies' implementation of its new direct-to-consumer "guiding principles" before an independent panel will begin analyzing compliance and progress




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts